The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Risk Factors for Cardiovascular Disease in Systemic Lupus Erythematosus
Abstract
Background Cardiovascular disease (CVD) is overrepresented in patients with systemic lupus erythematosus (SLE). We determined the prevalence of traditional and nontraditional risk factors for CVD in SLE patients with and without CVD compared with controls. Methods and Results Twenty-six women (aged 52±8.2 years) with SLE and a history of CVD (SLE cases) were compared with 26 age-matched women with SLE but without manifest CVD (SLE controls) and 26 age-matched population-based control women (population controls). Common carotid intima-media thickness (IMT) was measured by B-mode ultrasound as a surrogate measure of atherosclerosis. SLE cases had increased IMT compared with SLE controls ( P =0.03) and population controls ( P =0.001), whereas IMT of SLE controls did not differ from population controls. SLE cases had raised plasma concentrations of circulating oxidized LDL (OxLDL; P =0.03), as measured by the monoclonal antibody EO6, and autoantibodies to epitopes of OxLDL ( P <0.001); dyslipidemia with raised triglycerides ( P <0.001) and lipoprotein(a) ( P =0.002) and decreased HDL-cholesterol concentrations ( P =0.03); raised α-1-antitrypsin ( P =0.002), lupus anticoagulant ( P =0.007), and homocysteine levels ( P =0.03); more frequent osteoporosis ( P =0.03); and a higher cumulative prednisolone dose ( P =0.05) compared with SLE controls. Disease duration, smoking, blood pressure, body mass index, and diabetes mellitus did not differ significantly between the groups. Conclusions α set of distinct CVD risk factors separate SLE cases from SLE controls and population controls. If confirmed in a prospective study, they could be used to identify SLE patients at high risk for CVD in order to optimize treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Gladman, D., Ginzler, E., Goldsmith, C., Fortin, P., Liang, M., Sanchez‐Guerrero, J., Urowitz, M., Bacon, P., Bombardieri, S., Hanly, J., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390303 · Cited by 2,582
Manzi, S., Meilahn, E. N., Rairie, J. E., Conte, C. G., Medsger, T. A., Jansen-McWilliams, L., D'Agostino, R. B., & Kuller, L. H. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009122 · Cited by 1,834
McNeil, H. P., Simpson, R. J., Chesterman, C. N., & Krilis, S. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4120 · Cited by 1,595
The oxidation hypothesis of atherosclerosis
Witztum, J. L. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92346-9 · Cited by 1,389
Self-citationHarris, E. N., Boey, M. L., Mackworth-Young, C. G., Gharavi, A. E., Patel, B. M., Loizou, S., & Hughes, G. R. V. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91267-9 · Cited by 1,383
Is Type II diabetes mellitus a disease of the innate immune system?
Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,041
Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence
Eikelboom, J. W., Lonn, E., Genest, J., Hankey, G., & Yusuf, S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-5-199909070-00008 · Cited by 908
Palinski, W., Ylä-Herttuala, S., Rosenfeld, M. E., Butler, S. W., Socher, S. A., Parthasarathy, S., Curtiss, L. K., & Witztum, J. L. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.3.325 · Cited by 616
Self-citationShih, D. M., Xia, Y.-R., Wang, X.-P., Miller, E., Castellani, L. W., Subbanagounder, G., Cheroutre, H., Faull, K. F., Berliner, J. A., Witztum, J. L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910376199 · Cited by 425
Self-citationPlasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus
Petri, M., Roubenoff, R., Dallal, G. E., Nadeau, M. R., Selhub, J., & Rosenberg, I. H. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03032-2 · Cited by 419
Carlson, K. (1973) · Journal of Clinical Pathology · doi:10.1136/jcp.s1-5.1.32 · Cited by 419
Vaarala, O., Aho, K., Palosuo, T., Alfthan, G., Jauhiainen, M., & Leirisalo-Repo, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)91213-6 · Cited by 409
Hak, A. E., Pols, H. A. P., van Hemert, A. M., Hofman, A., & Witteman, J. C. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.8.1926 · Cited by 375
Hamsten, A., Björkholm, M., Norberg, R., De Faire, U., & Holm, G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92258-0 · Cited by 356
Self-citationOutiVaarala, MattiMänttäri, VesaManninen, LeenaTenkanen, MarjaPuurunen, KimmoAho, & TimoPalosuo (1995) · Circulation · Cited by 305
Borba, E., & Bonfá, E. (1997) · Lupus · doi:10.1177/096120339700600610 · Cited by 289
Induction of T-cell activation by oxidized low density lipoprotein.
Frostegård, J., Wu, R., Giscombe, R., Holm, G., Lefvert, A. K., & Nilsson, J. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.4.461 · Cited by 245
Measurement of systemic lupus erythematosus activity in clinical research
Liang, M. H., Socher, S. A., Roberts, W. N., & Esdaile, J. M. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310701 · Cited by 208
Enhanced In Vivo Lipid Peroxidation at Elevated Plasma Total Homocysteine Levels
Voutilainen, S., Morrow, J. D., Roberts, L. J., Alfthan, G., Alho, H., Nyyssönen, K., & Salonen, J. T. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.5.1263 · Cited by 205
Carotid Intima-Media Thickness and Plaque in Borderline Hypertension
Lemne, C., Jogestrand, T., & de Faire, U. (1995) · Stroke · doi:10.1161/01.str.26.1.34 · Cited by 185
Self-citationAutoantibodies to OxLDL Are Decreased in Individuals With Borderline Hypertension
Wu, R., Fairé, U. D., Lemne, C. E., Witztum, J. L., & Frostegård, J. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.53 · Cited by 120
Self-citationLipoprotein(a) levels in systemic lupus erythematosus.
Borba, E. F., Santos, R. D., Bonfá, E., et al. (1994) · PubMed · Cited by 109
Anti-inflammatory drugs in experimental atherosclerosis
Makheja, A. N., Bloom, S., Muesing, R. A., et al. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90099-3 · Cited by 67
Hörkkö, S., Olee, T., Mo, L., Branch, D. W., Woods, V. L., Palinski, W., Chen, P. P., & Witztum, J. L. (2001) · Circulation · doi:10.1161/01.cir.103.7.941 · Cited by 65
Self-citationEchocardiographic findings, lipids and lipoprotein(a) in patients with systemic lupus erythematosus
Rantapää‐Dahlqvist, S., Neumann-Andersen, G., Backman, C., Dahlén, G., & Stegmayr, B. G. (1997) · Clinical Rheumatology · doi:10.1007/bf02247842 · Cited by 23
Cited by
Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus
Roman, M. J., Shanker, B.-A., Davis, A., Lockshin, M. D., Sammaritano, L., Simantov, R., Crow, M. K., Schwartz, J. E., Paget, S. A., Devereux, R. B., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035471 · Cited by 1,427
D'Cruz, D. P., Khamashta, M. A., & Hughes, G. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60279-7 · Cited by 992
Premature Coronary-Artery Atherosclerosis in Systemic Lupus Erythematosus
Asanuma, Y., Oeser, A., Shintani, A. K., Turner, E., Olsen, N., Fazio, S., Linton, M. F., Raggi, P., & Stein, C. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035611 · Cited by 892
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
van Vollenhoven, R. F., Mosca, M., Bertsias, G., Isenberg, D., Kuhn, A., Lerstrøm, K., Aringer, M., Bootsma, H., Boumpas, D., Bruce, I. N., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-205139 · Cited by 740
Kavey, R.-E. W., Allada, V., Daniels, S. R., Hayman, L. L., McCrindle, B. W., Newburger, J. W., Parekh, R. S., & Steinberger, J. (2006) · Circulation · doi:10.1161/circulationaha.106.179568 · Cited by 707
Metadata
- Authors
- Svenungsson, E., Jensen-Urstad, K., Heimbürger, M., Silveira, A., Hamsten, A., de Faire, U., Witztum, J. L., & Frostegård, J.
- Venue
- Circulation
- Published
- 2001-10-16
- Volume
- 104
- Issue
- 16
- Pages
- 1887-1893
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2133031701
- Cited by
- 500
- References
- 28
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.